Analgesic mechanism of Goshajinkigan for neuropathic pain-Reference-Cited by-同舟云学术

Analgesic mechanism of Goshajinkigan for neuropathic pain

Published:2021-09-30 Issue:3 Volume:36 Page:154-162
ISSN:0915-8588
Container-title:PAIN RESEARCH
language:en
Short-container-title:

Author:

Nakanishi Miho¹,Fukui Sei²,Kitagawa Hirotoshi¹

Affiliation:

1. Department of Anesthesiology, Shiga University of Medical Science

2. Department of Anesthesiology, Pain Management Clinic, Interdisciplinary Pain Management Center, Shiga University of Medical Science Hospital

Publisher

Japanese Association for the Study of Pain

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/pain/36/3/36_3/_pdf

Reference25 articles.

1. 1) GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet, 390 (2017) 1211–1259.

2. 2) Ashburn, M.A., Staats, P.S., Management of chronic pain, Lancet, 1999 (1999) 1865–1869.

3. 3) Platts–Mills, T.F., Hunold, K.M., Weaver, M.A., Dickey, R.M, Fernandez. A.R., Fillingim, R.B., Cairns, C.B., McLean, S.A., Pain treatment for older adults during prehospital emergency care: variations by patient gender and pain severity, J. Pain, 14 (2013) 966–974.

4. 4) 井上和秀, 大石了三, 【ペインクリニックで使用する薬の新展開】その他の話題エコファーマの実際・今後の展開, ペインクリニック, 31(別冊秋) (2010) S461–S471.

5. 5) Watanabe, K., Shimada, A., Miyaki, K., Hirakata, A., Matsuoka, K., Omae, K., Takei, I., Corrigendum to "Long–Term Effects of Goshajinkigan in Prevention of Diabetic Complications: A Randomized Open–Labeled Clinical Trial", Evid. Based Complement. Alternat. Med., 2016 (2016) 9567408.